Bingham Osborn & Scarborough’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-34,516
| Closed | -$142K | – | 169 |
|
|
2020
Q3 | $142K | Sell |
34,516
-137,686
| -80% | -$566K | 0.01% | 161 |
|
|
2020
Q2 | $441K | Hold |
172,202
| – | – | 0.04% | 93 |
|
|
2020
Q1 | $498K | Sell |
172,202
-87,761
| -34% | -$254K | 0.05% | 87 |
|
|
2019
Q4 | $985K | Buy |
259,963
+117,900
| +83% | +$447K | 0.08% | 66 |
|
|
2019
Q3 | $727K | Hold |
142,063
| – | – | 0.06% | 73 |
|
|
2019
Q2 | $881K | Sell |
142,063
-3,850
| -3% | -$23.9K | 0.08% | 63 |
|
|
2019
Q1 | $1.04M | Buy |
145,913
+11,805
| +9% | +$83.9K | 0.1% | 55 |
|
|
2018
Q4 | $1.15M | Buy |
134,108
+3,850
| +3% | +$32.9K | 0.12% | 44 |
|
|
2018
Q3 | $2.61M | Hold |
130,258
| – | – | 0.23% | 32 |
|
|
2018
Q2 | $3.37M | Sell |
130,258
-746
| -0.6% | -$19.3K | 0.32% | 27 |
|
|
2018
Q1 | $3.13M | Buy |
131,004
+8,641
| +7% | +$207K | 0.3% | 28 |
|
|
2017
Q4 | $4.15M | Buy |
122,363
+533
| +0.4% | +$18.1K | 0.38% | 24 |
|
|
2017
Q3 | $2.58M | Hold |
121,830
| – | – | 0.24% | 27 |
|
|
2017
Q2 | $2.13M | Hold |
121,830
| – | – | 0.2% | 29 |
|
|
2017
Q1 | $2.13M | Buy |
121,830
+4,380
| +4% | +$76.6K | 0.21% | 30 |
|
|
2016
Q4 | $1.99M | Sell |
117,450
-117,450
| -50% | -$1.99M | 0.21% | 29 |
|
|
2016
Q3 | $3.86M | Hold |
234,900
| – | – | 0.41% | 22 |
|
|
2016
Q2 | $3.56M | Buy |
234,900
+204,900
| +683% | +$3.1M | 0.41% | 21 |
|
|
2016
Q1 | $434K | Hold |
30,000
| – | – | 0.05% | 75 |
|
|
2015
Q4 | $850K | Hold |
30,000
| – | – | 0.1% | 42 |
|
|
2015
Q3 | $502K | Hold |
30,000
| – | – | 0.06% | 65 |
|
|
2015
Q2 | $787K | Buy |
+30,000
| New | +$787K | 0.1% | 47 |
|